| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From Paoli-Calmettes Institute, Marseilles, France
2 From La Conception Hospital, Marseilles, France
Objective: To assess the efficacy, permanence, and safety of thoracoscopic talc poudrage (TTP) for pleurodesis in malignant effusions.
Design: Retrospective.
Participants: Patients with lifetime follow-up who received TTP in two related centers in Marseilles, France.
Results: Three hundred sixty patients were included in this study: 88 had mesothelioma and 272 had pleural metastases. The mean follow-up time was 12 months (2 to 120). Of the 327 patients whose response could be evaluated, 90.2% had a successful pleurodesis at 1 month, and 82.1% had a lifelong pleural symphysis. Adverse effects included 1 death 3 days after the procedure in a patient with end-stage disease, fever (9.8%), empyema (2.5%), pulmonary infection (0.8%), and malignant invasion of the scar (1 patient).
Conclusions: TTP is an effective and safe method of lifelong pleurodesis. It should be performed early on in the history of malignant effusions to avoid the risk of respiratory failure, this being directly linked to the general and respiratory status of the patients at the time of the procedure.
Key Words: malignant effusions • mesothelioma • pleurodesis • talc poudrage • thoracoscopy
Submitted on December 20, 1995
Accepted on May 21, 1996
This article has been cited by other articles:
|
|
 |
|
  G. L. Ceresoli, A. Chiti, P. A. Zucali, M. Rodari, R. F. Lutman, S. Salamina, M. Incarbone, M. Alloisio, and A. Santoro Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography With [18F]Fluorodeoxyglucose J. Clin. Oncol., October 1, 2006; 24(28): 4587 - 4593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Froudarakis, M. Klimathianaki, and M. Pougounias Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest, February 1, 2006; 129(2): 356 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tremblay and G. Michaud Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest, February 1, 2006; 129(2): 362 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bilaceroglu, Y. Guo, M. L. Hawthorne, Z. Zhu, G. T. Stathopoulos, K. B. Lane, and R. W. Light Oral Forms of Tetracycline and Doxycycline Are Effective in Producing Pleurodesis Chest, November 1, 2005; 128(5): 3750 - 3756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kolschmann, A. Ballin, and A. Gillissen Clinical Efficacy and Safety of Thoracoscopic Talc Pleurodesis in Malignant Pleural Effusions Chest, September 1, 2005; 128(3): 1431 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Chest, March 1, 2005; 127(3): 909 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. G. Lee, M. H. Baumann, N. A. Maskell, G. W. Waterer, T. E. Eaton, R. J. O. Davies, J. E. Heffner, and R. W. Light Pleurodesis Practice for Malignant Pleural Effusions in Five English-Speaking Countries: Survey of Pulmonologists Chest, December 1, 2003; 124(6): 2229 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Montes, J. Ferrer, M. A. Villarino, B. Baeza, M. Crespo, and J. Garcia-Valero Influence of Talc Dose on Extrapleural Talc Dissemination after Talc Pleurodesis Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marchi, L. R. Teixeira, F. Vargas, P. Astoul, A. Fraticelli, A. Robaglia-Schlupp, and P. Cau Talc for Pleurodesis: Hero or Villain? Chest, July 1, 2003; 124(1): 416 - 417. [Full Text] [PDF]
|
|
|
|
 |
|
 G Antunes, E Neville, J Duffy, and N Ali BTS guidelines for the management of malignant pleural effusions Thorax, May 1, 2003; 58(90002): ii29 - 38. [Full Text]
|
|
|
|
|
|
Y. Aelony and R. Laniado-Laboren Talc Pleurodesis vs Iodopovidone Chest, April 1, 2003; 123(4): 1318 - 1319. [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Phillips, G. Asimakopoulos, and M. O. Maiwand Malignant pleural mesothelioma: outcome of limited surgical management Interactive CardioVascular and Thoracic Surgery, March 1, 2003; 2(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fraticelli, A. Robaglia-Schlupp, H. Riera, S. Monjanel-Mouterde, P. Cau, and P. Astoul Distribution of Calibrated Talc After Intrapleural Administration: An Experimental Study in Rats Chest, November 1, 2002; 122(5): 1737 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.E. Martin-Ucar, J.G. Edwards, A. Rengajaran, S. Muller, and D.A. Waller Palliative surgical debulking in malignant mesothelioma : Predictors of survival and symptom control Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1117 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn Management of malignant pleural effusions Eur. Respir. J., August 1, 2001; 18(2): 402 - 419. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Pien, M. J. Gant, C. L. Washam, and D. H. Sterman Use of an Implantable Pleural Catheter for Trapped Lung Syndrome in Patients With Malignant Pleural Effusion Chest, June 1, 2001; 119(6): 1641 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cardillo, F. Facciolo, M. Regal, L. Carbone, F. Corzani, A. Ricci, and M. Martelli Recurrences following videothoracoscopic treatment of primary spontaneous pneumothorax: the role of redo-videothoracoscopy Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 396 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. M. de Campos, F. S. Vargas, E. d. C. Werebe, P. Cardoso, L. R. Teixeira, F. B. Jatene, and R. W. Light Thoracoscopy Talc Poudrage : A 15-Year Experience Chest, March 1, 2001; 119(3): 801 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Sahn Talc Should Be Used for Pleurodesis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2023 - 2024. [Full Text]
|
|
|
|
|
|
G ANTUNES and E NEVILLE Management of malignant pleural effusions Thorax, December 1, 2000; 55(12): 981 - 983. [Full Text]
|
|
|
|
|
|
Management of Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001. [Full Text]
|
|
|
|
|
|
A. H. DIACON, C. WYSER, C. T. BOLLIGER, M. TAMM, M. PLESS, A. P. PERRUCHOUD, and M. SOLER Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1445 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bouros, M. Froudarakis, and N. M. Siafakas Pleurodesis : Everything Flows Chest, September 1, 2000; 118(3): 577 - 579. [Full Text] [PDF]
|
|
|
|
|
|
M. Glazer, N. Berkman, J. S. Lafair, and M. R. Kramer Successful Talc Slurry Pleurodesis in Patients With Nonmalignant Pleural Effusion Chest, May 1, 2000; 117(5): 1404 - 1409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Cerfolio, R. P. Tummala, W. L. Holman, G. L. Zorn, J. K. Kirklin, D. C. McGiffin, D. C. Naftel, and A. D. Pacifico A prospective algorithm for the management of air leaks after pulmonary resection Ann. Thorac. Surg., November 1, 1998; 66(5): 1726 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. C. Yim, H.-P. Liu, S. R. Hazelrigg, M. B. Izzat, A. L. K. Fung, T. M. Boley, and M. J. Magee Thoracoscopic Operations on Reoperated Chests Ann. Thorac. Surg., February 1, 1998; 65(2): 328 - 330. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
